Your browser doesn't support javascript.
loading
How do we define high and low dose intensity of heart failure medications: a scoping review.
Kwak, Min Ji; Wang, Qian; Onyebeke, Chukwuma; Holder, Travis; Goyal, Parag; Aparasu, Rajender; Dhoble, Abhjeet; Holmes, Holly M.
Afiliação
  • Kwak MJ; The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA. min.ji.kwak@uth.tmc.edu.
  • Wang Q; The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA.
  • Onyebeke C; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Holder T; Texas Medical Center Library, Houston Academy of Medicine, Texas Medical Center, Houston, TX, USA.
  • Goyal P; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Aparasu R; Department of Pharmaceutical Health Outcomes and Policy, University of Houston, Houston, TX, USA.
  • Dhoble A; The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA.
  • Holmes HM; The University of Texas Health Science Center at Houston, 6431 Fannin Street, Houston, TX, 77030, USA.
BMC Cardiovasc Disord ; 23(1): 478, 2023 09 27.
Article em En | MEDLINE | ID: mdl-37759279

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Angiotensina / Insuficiência Cardíaca Tipo de estudo: Guideline / Systematic_reviews Limite: Aged / Humans Idioma: En Revista: BMC Cardiovasc Disord Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antagonistas de Receptores de Angiotensina / Insuficiência Cardíaca Tipo de estudo: Guideline / Systematic_reviews Limite: Aged / Humans Idioma: En Revista: BMC Cardiovasc Disord Ano de publicação: 2023 Tipo de documento: Article